DLL3 and lung neuroendocrine neoplasm: These findings suggest that DLL3 and ASCL1 are not only correlated in their expression but may also be involved in the neuroendocrine phenotype of lung neuroendocrine tumors and could serve as potential therapeutic targets or prognostic indicators in these diseases.